DiaMedica Therapeutics Inc (NASDAQ: DMCAF) stock closed at $4.01 on 7/10/19 after a major decline of -10.7%. Moreover, unusually high trading volume at 172% of normal accompanied the decline. The stock has declined -17.5% during the last week and has been extremely weak relative to the market over the last nine months.
Current PriceTarget Research Rating
With future capital returns forecasted to be below the cost of capital, DMCAF is expected to be a major Value Eraser.
DMCAF is currently unrated.
The stock is currently unrated.